Unicycive Therapeutics (UNCY)

• Market cap: $199M
• 1 day: -5.72%
• 5 days: 3.57%
• 1 month: -11.26%
• 3 months: 3.42%
• 6 months: 16.37%
• Year to date: 25%
• 1 year: 13.64%
• 5 years: -87.61%
• 10 years: -87.61%
• Sector: Healthcare
• Industry: Biotechnology

About: Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two key product candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.

Employees: 22